PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Racial difference in blood clotting warrants a closer look at heart attack medications

2013-11-11
(Press-News.org) Contact information: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University
Racial difference in blood clotting warrants a closer look at heart attack medications (PHILADELPHIA) Thomas Jefferson University researchers have discovered that the formation of blood clots follows a different molecular route in African Americans versus European Americans, providing a new understanding of the effects of race on heart disease. The finding could one day help doctors provide more individualized treatment of heart disease and other blood-clot-related illnesses, according to research publishing online November 10th in Nature Medicine.

The finding may also provide an additional explanation for the disparity between outcomes in black and white patients with heart disease, which is the most common killer of white and black Americans. Compared to white patients, blacks have a two-fold increased incidence of heart disease and have a lower long-term survival. The reasons for this racial disparity are complex, and include racial bias, a higher prevalence of traditional risk factors such in blacks, and differences in socioeconomic status, management and environment. However, even when these factors are considered, the survival of black heart attack patients is 2 and a half times lower than white patients. This suggests there are yet-to-be identified factors accounting for the racial disparity in heart disease.

"We may need to consider our patient's race when using certain heart disease therapies," said lead author of the research Paul Bray, M.D., Director of Thomas Jefferson University's Cardeza Foundation for Hematologic Research.

Anti-platelet medications, such as aspirin, are commonly prescribed to prevent heart attack or stroke. These medications function by blocking the clot-forming activity of platelets – small cells that normally circulate in the blood stream and congeal around damaged or atherosclerotic blood vessels. The plaques in atherosclerotic vessels can occasionally rupture, causing the formation of a platelet plug that clogs blood vessels and can lead to heart attack or stroke. However, there is considerable variability in how patients respond to these medications, which confounds physicians who must deduce the appropriate drug and proper dose for each patient. Now, researchers from Thomas Jefferson University have identified some of the genetic differences behind these variations, which could help doctors treat racial groups with a more personalized and effective approach.

"Differences in platelet biology could be part of the explanation of the disparity," says Dr. Bray.

To investigate whether the variation among different individuals had a racial component, Dr. Bray and collaborators from Baylor Medical College, Harvard Medical School and the New York and Puget Sound Blood Centers analyzed platelets from blood samples of 154 young healthy subjects that included 70 blacks and 84 whites. Self-reported race was confirmed with genetic tests that verified geographic (African or European) ancestry. Unexpectedly, the researchers found that platelets from black donors clotted faster and to a greater extent in response to the naturally occurring clotting agent, thrombin that specifically triggered one of the platelet-activating receptors, called PAR4. No racial differences were seen with other clotting agents.

Thrombin is the most potent platelet activator in the body, and it is targeted for suppression by numerous blood-thinning medications. However, newer drugs that target thrombin inhibit specific members of the PAR family of receptors. For example, the drug vorapaxar, currently in development for patients with a history of heart disease, specifically inhibits the PAR1 receptor. If PAR1 is blocked by vorapaxar, then PAR4 is the only means by which thrombin can activate platelets, and the Jefferson scientists showed that in this setting thrombin more potently activated platelets from blacks. It remains to be determined how or if these findings relate to drugs that are currently prescribed or to those currently in development.

Further molecular studies identified a novel gene called PCTP that mediated platelet activation through PAR4. PCTP was expressed at higher levels in platelets from blacks and appears to be a major contributor to the racial difference in blood clotting. Furthermore, a microRNA was identified that silenced the expression of PCTP; this microRNA was expressed at higher levels in platelets from whites than blacks and may contribute to the lower levels of thrombin activation through the PAR4 receptor in whites.

In fact, the researchers found many silencing microRNAs were more actively expressed in whites than in blacks, at least in platelets, suggesting that other aspects of platelet biology may be regulated differently depending on race. Uncovering the genes that these microRNAs suppress could help researchers hone in on individual differences in platelet function, and eventually how these differences contribute to disease and response to anti-clotting treatments.

"In this age where there is such a focus on delivering personalized medicine, we should embrace these differences to try to give our patients better care," says Dr. Bray.

###

This work was supported by National Institutes of Health grant HL102482 and the Cardeza Foundation for Hematologic Research, as well as support from NIH grants DK48872 and DK56626.

The authors report no conflicts of interest.

About Jefferson

Thomas Jefferson University (TJU), the largest freestanding academic medical center in Philadelphia, is nationally renowned for medical and health sciences education and innovative research. Founded in 1824, TJU includes Jefferson Medical College (JMC), one of the largest private medical schools in the country and ranked among the nation's best medical schools by U.S. News & World Report, and the Jefferson Schools of Nursing, Pharmacy, Health Professions, Population Health and the Graduate School of Biomedical Sciences. Jefferson University Physicians is TJU's multi-specialty physician practice consisting of the full-time faculty of JMC. Thomas Jefferson University partners with its clinical affiliate, Thomas Jefferson University Hospitals.

Article reference: L.C. Edelstein, et al., "Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c," Nature Medicine, DOI:10.1038/nm.3385, 2013.

END



ELSE PRESS RELEASES FROM THIS DATE:

Research by Saint Louis University scientists offers way to disrupt fibrosis

2013-11-11
Research by Saint Louis University scientists offers way to disrupt fibrosis Nature Medicine paper pinpoints where, how to intervene ST. LOUIS – A team of scientists that includes Saint Louis University researchers has identified a new way to intervene in the molecular ...

The contribution of coding variants to psoriasis much smaller than thought

2013-11-11
The contribution of coding variants to psoriasis much smaller than thought The latest study was published online in Nature Genetics November 10, 2013, Shenzhen, China - Coding variants in immune disease-related genes play only a small part in the overall genetic risk for psoriasis, according ...

Hope for transplant patients as study finds key to organ scarring

2013-11-11
Hope for transplant patients as study finds key to organ scarring Uni of Edinburgh news release Patients with damaged organs could be helped by new treatments after scientists have discovered how tissues scar. Researchers say that the finding could pave ...

Cause of genetic disorder found in 'dark matter' of DNA

2013-11-11
Cause of genetic disorder found in 'dark matter' of DNA For the first time, scientists have used new technology which analyses the whole genome to find the cause of a genetic disease in what was previously referred to as 'junk DNA' For the first time, scientists ...

All aboard the nanotrain network

2013-11-11
All aboard the nanotrain network VIDEO: Nanotrain transport system created by Oxford University scientists in action: The time-lapse ...

'Saving our fish' needs more than a ban on discarding

2013-11-11
'Saving our fish' needs more than a ban on discarding Banning the practice of throwing unmarketable or over-quota fish back into the sea is just one of the measures needed to deliver sustainable fisheries according to new research from the University of East Anglia ...

Fast-mutating DNA sequences shape early development; guided evolution of uniquely human traits

2013-11-11
Fast-mutating DNA sequences shape early development; guided evolution of uniquely human traits Gladstone-led study reveals new insight into origins of our species SAN FRANCISCO, CA—November 11, 2013—What does it mean to be human? According to scientists ...

Un-junking junk DNA

2013-11-11
Un-junking junk DNA A study led by researchers at the University of California, San Diego School of Medicine shines a new light on molecular tools our cells use to govern regulated gene expression. The study was published on line in advance of print November ...

Research reveals roles for exercise and diet in aging, depression

2013-11-11
Research reveals roles for exercise and diet in aging, depression Lifestyle changes in diet and exercise show promise for learning, depression in teens, and more SAN DIEGO — New studies released today underscore the potential impact of healthy lifestyle choices in treating ...

Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis

2013-11-11
Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis SAN DIEGO — Scientists are gaining a new level of understanding of multiple sclerosis (MS) that may lead to new treatments and approaches to controlling the chronic disease, ...

LAST 30 PRESS RELEASES:

What 3I/ATLAS tells us about other solar systems

University of Cincinnati allergist receives $300,000 grant to research rare esophageal disease

Ohio State scientists advance focus on nuclear propulsion

New study reveals a hidden risk after cervical cancer

Environment: Indigenous Amazon territories benefit human health

Zoology: Octopuses put their best arm forward for every task

New research reveals wild octopus arms in action

NEW STUDY: Across eight Amazon countries, forests on Indigenous lands reduce spread of 27 diseases – From respiratory ailments to illnesses spread by insects, animals

How many ways can an octopus flex its supple arms? Now we know

Analysis of ‘magic mushroom’ edibles finds no psilocybin but many undisclosed active ingredients

Modifiable parental factors and adolescent sleep during early adolescence

Excess HIV infections and costs associated with reductions in HIV prevention services in the us

Clocks created from random events can probe ‘quantumness’ of universe

Schaeffer Center white paper outlines FDA reforms to boost pharmaceutical innovation and expand access 

Michael Welsh, MD, wins Lasker Award for cystic fibrosis research

The metals reveal: The Bronze Age was more connected than we previously thought

Portable light-based brain monitor shows promise for dementia diagnosis

AI tools uncover new link between idiopathic pulmonary fibrosis and aging

Researchers revive the pinhole camera for next-gen infrared imaging

Gender gap in Africa’s water leadership undermines fair policymaking

City of Hope Research Spotlight, August 2025

NIH funds study of type 1 diabetes development

Preventing recidivism after imprisonment

Mass General Brigham’s Kraft Center announces winner and finalists of the 2025 Kraft Prize for Excellence and Innovation in Community Health

Researchers develop novel approach for experimentally measuring the Unruh effect with high accuracy

Americans’ knowledge of civics increases, Annenberg survey finds

Multifaceted benefits of ginseng and its extracts: a brief review of immunomodulation, quality of life improvement, and antitumor potential

Korea University study reveals hidden complexity in recurrent brain tumors

How an immune cell receptor dampens the fight against fungal infection

SeoulTech researchers uncover high PAHs in common foods

[Press-News.org] Racial difference in blood clotting warrants a closer look at heart attack medications